Other investigators reported that the expression level of TMEM220 is low in hepatocellular carcinoma and is associated with poor prognosis in patients, indicating that downregulation of TMEM220 promotes the progression of hepatocellular carcinoma [31]. The gene discussed is TMEM220; the disease is hepatocellular carcinoma.